Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an AHSCT in Non-Hodgkin's Lymphoma Patients
Clinical trial NCT00562978 · COMPLETED
Trial details
- NCT number
- NCT00562978
- Sponsor
- City of Hope Medical Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-05-16
- Primary completion
- 2018-05-21
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.